Transforming and Supporting Patient Care - Health Professions ...

361Chapter 14 – Profession of Pharmacyv) cardiovascular drugs,vi) CNS agents – analgesics and antipyretics - NSAIDs,anticonvulsants, psychotherapeutic agents,anorexigenic agents and respiratory and cerebralstimulants, anxiolytics, sedatives and hypnotics,antimanic agents, antimigraine agents,antiparkinsonian agents,vii) electrolytic, caloric and water balance,viii) respiratory tract agents,ix) eye, ear, nose and throat preparations,x) gastrointenstinal drugs,xi) hormones and synthetic substitutes,xii) skin and mucous membrane agents,xiii) vitamins, andxiv) miscellaneous therapeutic agents.(c) A member may only prescribe drugs under the authority ofparagraph 4 of section 4 of the Act:(a) for the purposes of either medication therapymanagement, smoking cessation therapy or as otherwiseprescribed in the regulations; and(b) only those drugs with the classes designated in subsection6(b) that are listed in the Drug List and must prescribethose listed drugs in accordance with the terms,limitations and conditions contained in the Drug List.(7) For the purposes of clause 28(6)(c),“medication therapy management” means professional activitiesand responsibilities of the member designed to optimizetherapeutic outcomes for a patient according to the needs of theindividuals being treated as set out in detail in the standards ofpractice established and published by the College from time totime; and“smoking cessation therapy” means professional activities andresponsibilities of the member designed to assess, initiate andmonitor the most appropriate therapy for smoking cessation,including the prescribing of designated drugs as set out inregulation and in the standards of practice established andpublished by the College from time to time.6. That section 29.1(a) of Ontario Regulation 202/94 under the PharmacyAct, 1991 (General) be repealed and the following substituted:29.1 (a) prescribe, dispense, sell or compound drugs;HPRAC Critical Links January 2009